These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 3297633)
1. [Prolactin, depression and antidepressive agents. Review of the literature]. Ben Hadj Ali B Encephale; 1987; 13(3):101-12. PubMed ID: 3297633 [TBL] [Abstract][Full Text] [Related]
2. Central serotonergic changes following antidepressant treatment: a neuroendocrine assessment. Leatherman ME; Ekstrom RD; Corrigan M; Carson SW; Mason G; Golden RN Psychopharmacol Bull; 1993; 29(2):149-54. PubMed ID: 8290659 [TBL] [Abstract][Full Text] [Related]
3. [Different effects of tricyclic (clomipramine and amitriptyline) and tetracyclic (maprotiline) antidepressors on the release of thyroid stimulating hormone, prolactin and growth hormone to thyrostimulating releasing hormone in patients with psychoaffective disorders (author's transl)]. Schlienger JL; Kapfer MT; Singer L; Stephan F Acta Psychiatr Belg; 1980; 80(5):584-99. PubMed ID: 6786002 [TBL] [Abstract][Full Text] [Related]
4. The biochemistry of depression. A survey of monoaminergic, neuroendocrinological, and bio-rhythmic disturbances in endogenous depression. Lingjaerde O Acta Psychiatr Scand Suppl; 1983; 302():36-51. PubMed ID: 6132523 [No Abstract] [Full Text] [Related]
5. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients. Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427 [TBL] [Abstract][Full Text] [Related]
6. Clinical response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini review. Yoshimura R; Nakamura J; Shinkai K; Ueda N Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):611-6. PubMed ID: 15276685 [TBL] [Abstract][Full Text] [Related]
7. Clinical and biochemical aspects of depressive disorders: III. Treatment and controversies. Caldecott-Hazard S; Schneider LS Synapse; 1992 Feb; 10(2):141-68. PubMed ID: 1585257 [TBL] [Abstract][Full Text] [Related]
8. Potentiation strategies for treatment-resistant depression. Ros S; Agüera L; de la Gándara J; Rojo JE; de Pedro JM Acta Psychiatr Scand Suppl; 2005; (428):14-24, 36. PubMed ID: 16307616 [TBL] [Abstract][Full Text] [Related]
9. A silver bullet for the treatment of depression? Duman RS Neuron; 2007 Sep; 55(5):679-81. PubMed ID: 17785173 [TBL] [Abstract][Full Text] [Related]
11. 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs? Stahl S Psychopharmacol Bull; 1994; 30(1):39-43. PubMed ID: 7972628 [TBL] [Abstract][Full Text] [Related]
12. [Thyrotropin-releasing hormone in psychiatry: marker, predictor and therapeutical tool]. Babinski T; Paunović VR Srp Arh Celok Lek; 1994; 122(11-12):341-3. PubMed ID: 17974414 [TBL] [Abstract][Full Text] [Related]
13. Effects of postnatal isolation rearing and antidepressant treatment on the density of serotonergic and noradrenergic axons and depressive behavior in rats. Kuramochi M; Nakamura S Neuroscience; 2009 Sep; 163(1):448-55. PubMed ID: 19524023 [TBL] [Abstract][Full Text] [Related]
14. Invivo antioxidant status: a putative target of antidepressant action. Zafir A; Ara A; Banu N Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):220-8. PubMed ID: 19059298 [TBL] [Abstract][Full Text] [Related]
15. New approaches to antidepressant drug discovery: beyond monoamines. Berton O; Nestler EJ Nat Rev Neurosci; 2006 Feb; 7(2):137-51. PubMed ID: 16429123 [TBL] [Abstract][Full Text] [Related]
16. [Research progress on therapeutic mechanism of depression treated by traditional chinese medicine]. Mao QQ; Huang Z Zhongguo Zhong Yao Za Zhi; 2007 May; 32(10):877-80. PubMed ID: 17655134 [TBL] [Abstract][Full Text] [Related]